Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1989 USD | -4.14% | -14.56% | -86.65% |
Apr. 16 | Barnes & Noble Education to Receive $95 Million Investment, Adopts Short-Term Poison Pill; Shares Plunge | MT |
Apr. 16 | Barnes & Noble Education Adopts Short-Term Poison Pill | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Other Specialty Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-86.65% | 10.57M | C+ | ||
-16.04% | 1.81B | B | ||
+46.67% | 210M | - | ||
+55.63% | 69.24M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BNED Stock
- Ratings Barnes & Noble Education, Inc.